CAR-T Cell Therapy Shows Promise Against Treatment-Resistant Multiple Myeloma
Genetically modified immune cells target blood cancer that stopped responding to standard treatments in 28-patient trial.
320 articles in this topic
Genetically modified immune cells target blood cancer that stopped responding to standard treatments in 28-patient trial.
Researchers modified children's own immune cells to fight B-cell leukemia and lymphoma when standard treatments failed.
Phase II trial tests checkpoint inhibitors given before surgery to shrink tumors and improve outcomes in stage III-IV melanoma patients.
New viral therapy ASP9801 targets solid tumors directly, potentially offering hope for patients with advanced metastatic cancer.
First study tests whether supervised exercise training is safe and beneficial for bladder cancer patients during treatment.
Researchers tracked immune changes during intensive radiation treatment to optimize cancer therapy and potential immunotherapy combinations.
French study explores how tiny cellular packages in blood could predict cancer recurrence and guide treatment decisions.
Despite decades of research, blood tests for early pancreatic cancer detection remain elusive due to fundamental biological barriers.
New liquid biopsy using exosomes could revolutionize screening for colorectal cancer in people under 50, when traditional screening isn't recommended.
Combining chemotherapy with immunotherapy before surgery significantly increases complete response rates in early-stage lung cancer patients.
Scientists discover ALPK1 receptor agonists trigger powerful anti-tumor immunity, offering new immunotherapy approach beyond current treatments.
Breakthrough therapy converts tumor cells into antigen-presenting cells that train immune system to destroy cancer.